Nuclear Medicine and Biology
Volume 33, Issue 8 , Pages 985-989, November 2006

Evaluation of [14C]phenylacetate as a prototype tracer for the measurement of glial metabolism in the rat brain

  • Osamu Inoue

      Affiliations

    • Biomedical Physics and Engineering Laboratory, Course of Allied Health Sciences, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 6 6879 2563; fax: +81 6 6879 2563.
  • ,
  • Rie Hosoi

      Affiliations

    • Biomedical Physics and Engineering Laboratory, Course of Allied Health Sciences, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan
  • ,
  • Sotaro Momosaki

      Affiliations

    • Biomedical Physics and Engineering Laboratory, Course of Allied Health Sciences, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan
  • ,
  • Keisuke Yamamoto

      Affiliations

    • Biomedical Physics and Engineering Laboratory, Course of Allied Health Sciences, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan
  • ,
  • Misato Amitani

      Affiliations

    • Biomedical Physics and Engineering Laboratory, Course of Allied Health Sciences, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan
  • ,
  • Masatoshi Yamaguchi

      Affiliations

    • Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka 814-0180, Japan
  • ,
  • Antony Gee

      Affiliations

    • Clinical Research Unit, GlaxoSmithKline, ACCI, Addenbrookes Hospital, Cambridge, UK

Received 1 August 2006; received in revised form 21 August 2006; accepted 29 August 2006.

Abstract 

[14C]Phenylacetate was designed as a prototype tracer for the measurement of glial metabolism, and its potency in comparison with that of [14C]acetate was evaluated in this study. Normal rats were intravenously injected with [14C]phenylacetate or [14C]acetate, and radioactivity concentrations were measured in the plasma, cerebral cortex, cerebellum and peripheral tissues by dissection method. In addition, [14C]phenylacetate uptake in the rat brain was compared by autoradiography with that of [14C]acetate following the injection of fluorocitrate, a selective glial toxin, into the brain. [14C]Phenylacetate was rapidly taken up into the brain and was retained at high levels up to 20 min postadministration. The levels of [14C]phenylacetate in the cerebral cortex were about threefold higher than those of [14C]acetate at 1 min postinjection. Microinjection of fluorocitrate into the right striatum resulted in a significant decrease of the uptake of both [14C]phenylacetate and [14C]acetate into the right striatum. Radiochemical analysis confirmed the rapid hydrolysis of [14C]phenylacetate in the rat brain, with less than 20% of radioactivity representing unmetabolized [14C]phenylacetate at 1 min postinjection. These results suggest that [14C]phenylacetate is rapidly taken up into the brain and is hydrolyzed and converted to [14C]acetate. [14C]Phenylacetate may have the potential to serve as a tracer for the measurement of glial metabolism in an intact brain.

Keywords: [14C]Phenylacetate, Hydrolysis, Carboxylesterase, Rat, Brain

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0969-8051(06)00162-4

doi:10.1016/j.nucmedbio.2006.08.007

Nuclear Medicine and Biology
Volume 33, Issue 8 , Pages 985-989, November 2006